TL;DR
This study reveals a causal link between an imbalanced gut microbiome (dysbiosis) and the development of hypertension. By analyzing human gut bacteria and metabolites, and then transplanting human gut microbes into germ-free mice, the researchers demonstrate that gut dysbiosis can directly contribute to elevated blood pressure, highlighting the importance of early intervention for pre-hypertension.
What Problem Does This Paper Address?
Hypertension is a major global health concern, yet its precise causes remain complex and not fully understood, involving a mix of genetic and environmental factors. While the gut microbiome has been implicated in other metabolic diseases, its specific role in hypertension development was largely unknown. This paper aims to fill this knowledge gap by investigating whether gut microbiota dysbiosis is a consequence of hypertension or a contributing factor to its pathogenesis. The study also seeks to understand how pre-hypertension, an intermediate stage, relates to gut microbial changes and whether these changes can be used for early detection.
Methods
The researchers employed a multi-pronged approach:
- Metagenomic Sequencing: They performed shotgun metagenomic sequencing on stool samples from a large cohort of individuals across three groups: healthy controls, pre-hypertensive (pHTN), and primary hypertensive (HTN) patients. This allowed them to analyze the composition and diversity of the gut microbial communities.
- Metabolomic Analysis: Serum samples were analyzed using liquid chromatography-mass spectrometry (LC/MS) to identify metabolic profiles and understand how gut microbial changes might influence host metabolism.
- Co-abundance Gene Group (CAG) Analysis: Genes with similar abundance patterns across samples were clustered into CAGs to identify microbial functional units associated with different health states.
- Machine Learning Classification: Random forest models were used to build classifiers based on CAGs and metabolites to distinguish between healthy individuals and those with pHTN or HTN.
- Fecal Microbiota Transplantation (FMT): To establish causality, fecal microbiota from hypertensive patients was transplanted into germ-free mice. This allowed researchers to observe if elevated blood pressure could be transferred along with the gut microbes.
Datasets
The study utilized two main datasets:
- Primary Cohort: Stool samples from 196 Chinese individuals (41 healthy controls, 56 pHTN, 99 HTN) from the Kailuan Group Corporation cohort.
- Verification Cohort: A smaller set of samples from a previous study on type 2 diabetes, including 3 normotensive controls and 3 HTN patients.
- Fecal Microbiota Transplantation Model: Germ-free mice were used as recipients for human fecal microbiota.
Key Insights and Ideas
- Pre-hypertension is not just a precursor: The study found that the gut microbiome in pre-hypertensive individuals was remarkably similar to that of hypertensive patients, suggesting that dysbiosis might begin even before overt hypertension develops. This underscores the importance of early intervention.
- Prevotella as a potential culprit: The genus Prevotella was consistently enriched in the gut microbiomes of pHTN and HTN individuals, and its abundance was linked to specific metabolites associated with hypertension. This points to Prevotella as a potential key player in the inflammatory processes contributing to hypertension.
- Gut microbes can directly influence blood pressure: The fecal microbiota transplantation experiment provided crucial evidence for a causal role. Mice receiving gut microbes from hypertensive donors developed elevated blood pressure, directly demonstrating that gut dysbiosis can transmit hypertensive phenotypes.
- Metabolites as biomarkers: The study identified specific serum metabolites that were altered in pHTN and HTN patients and correlated with specific gut bacteria, suggesting their potential as biomarkers for early detection and diagnosis.
Key Results
- Reduced microbial diversity: Both pHTN and HTN groups showed significantly decreased microbial richness and diversity compared to healthy controls.
- Distinct enterotypes: The study identified two main enterotypes, with one enriched in Prevotella being more prevalent in pHTN and HTN individuals, while the other, enriched in Bacteroides, was more common in controls.
- Altered bacterial composition: Genera like Prevotella and Klebsiella were overrepresented in pHTN and HTN, while beneficial bacteria like Faecalibacterium and Roseburia were depleted.
- Functional shifts: Gut microbial functions related to amino acid biosynthesis, fatty acid utilization, and purine metabolism were decreased in pHTN and HTN, while functions related to LPS biosynthesis and export were increased, suggesting a pro-inflammatory state.
- Predictive classification: A classifier based on gut microbial CAGs and metabolites could accurately distinguish pHTN and HTN patients from controls, with an AUC of up to 0.91.
- Transmissible hypertension: Fecal microbiota transplantation from hypertensive patients to germ-free mice resulted in significantly higher systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean blood pressure (MBP) in the recipient mice.
Limitations and Future Work
- Limited donor diversity in FMT: The fecal microbiota transplantation experiment used a small number of donors (two HTN patients and one control). The authors suggest that larger studies with more donors are needed to further establish the magnitude of BP changes.
- Causality of specific metabolites: While correlations between gut microbes and metabolites were found, the direct metabolic pathways and whether these metabolites are directly produced by the gut microorganisms require further investigation.
- Mechanism of immune inflammation: The precise mechanisms by which gut bacterial metabolites contribute to the immune inflammatory system during hypertension development need further research.
- Early intervention strategies: While the study highlights the importance of early intervention for pHTN, further research is needed to develop and test specific interventions (e.g., dietary changes, probiotics) to restore gut microbial homeostasis.
- Further bacteria transfer experiments: The authors suggest that Prevotella, Klebsiella, and Enterobacter are potential candidates for future experiments to explore their precise mechanisms in BP regulation.
Summary updated